Good work Patong1 !! And fundamentally if they achieve the 5%...

Good work Patong1 !!

And fundamentally if they achieve the 5% market share of North America
Aust, Germany and UK the revenue is $250m as per the last presentation,
Then if RSH is trading on a 5 times revenue it will be way over $2 a share.... makes RSH look bloody cheap compared to some tech stocks out there... and if they become the ‘gold standard’ for asthma management then god only knows the valuation - a multiple of the $2 a share price based on a 5% market share of the countries above - what if it was 30% market share .: $12 per share?

Not even bringing into the equation Asia?

So aiming for 20c is only really the beginning of this journey in my opinion, the problem people are finding is getting stock... as I said there won’t be much around and it will only come out at higher prices based on history.